Skip to main content
. Author manuscript; available in PMC: 2024 Jul 10.
Published in final edited form as: Gynecol Oncol. 2022 Nov 18;168:92–99. doi: 10.1016/j.ygyno.2022.11.001

Figure 3 –

Figure 3 –

(A) CD8+ T cell infiltration is significantly increased in carboplatin treated groups compared to anti-VEGFR-2 with (B) elevated levels of CD4+ T cells noted across all treatment groups. (C) Representative photomicrographs of IHC-stained tissue sections show co-localization of CD8+ and CD4+ TIL populations in the carboplatin and anti-PD-1 treated groups and sparse detection in control or anti-VEGFR-2 groups. (n = 3–4 mice per group, in 2 experiments)